This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
PharmAthene, Inc., a biodefense company, develops and commercializes medical counter measures against biological and chemical threats in the United States.View PIP key stats
PharmAthene Inc - PIP - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates PharmAthene Inc as a
Sell with a ratings score of D-.
Report Snippet: We rate PHARMATHENE INC (PIP) a SELL. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and generally disappointing historical performance in the stock itself.